GILD Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 0.30%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $84,338,882.26

Gilead Sciences Insider Trading History Chart

Gilead Sciences Share Price & Price History

^$150.11

▼ -0.78 (-0.52%)

As of 09/18/2026 04:00 PM ET

Days: 30 | 90 | 365

Gilead Sciences Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/15/2026	Andrew D. Dickinson	CFO	Sell	3,000	$145.29	$435,870.00	164,096
9/15/2026	Johanna Mercier	Insider	Sell	3,000	$144.22	$432,660.00	116,684
9/1/2026	Daniel Patrick O'Day	CEO	Sell	15,000	$148.64	$2,229,600.00	577,133
8/26/2026	Anthony Welters	Director	Sell	18,000	$148.62	$2,675,160.00	12,894
8/20/2026	Jeffrey Bluestone	Director	Sell	5,000	$145.02	$725,100.00	10,066
8/17/2026	Andrew D. Dickinson	CFO	Sell	3,000	$138.36	$415,080.00	165,646
8/17/2026	Johanna Mercier	Insider	Sell	28,000	$137.64	$3,853,920.00	118,234
8/3/2026	Daniel Patrick O'Day	CEO	Sell	15,000	$130.31	$1,954,650.00	592,133
7/1/2026	Daniel Patrick O'Day	CEO	Sell	15,000	$126.29	$1,894,350.00	607,133
6/15/2026	Andrew D. Dickinson	CFO	Sell	3,000	$125.40	$376,200.00	171,646
6/15/2026	Johanna Mercier	Insider	Sell	3,000	$123.92	$371,760.00	124,234
6/1/2026	Daniel Patrick O'Day	CEO	Sell	15,000	$131.46	$1,971,900.00	617,567
5/15/2026	Andrew D. Dickinson	CFO	Sell	3,000	$132.27	$396,810.00	173,191
5/15/2026	Johanna Mercier	Insider	Sell	28,000	$131.29	$3,676,120.00	125,779
4/28/2026	Daniel Patrick O'Day	CEO	Sell	10,000	$129.16	$1,291,600.00	632,567
4/15/2026	Andrew D. Dickinson	CFO	Sell	3,000	$140.96	$422,880.00	176,191
4/15/2026	Johanna Mercier	Insider	Sell	3,000	$140.96	$422,880.00	128,779
3/16/2026	Andrew D. Dickinson	CFO	Sell	3,000	$144.23	$432,690.00	179,191
3/16/2026	Johanna Mercier	Insider	Sell	3,000	$144.23	$432,690.00	131,779
2/27/2026	Daniel Patrick O'Day	CEO	Sell	10,000	$144.79	$1,447,900.00	642,308
2/17/2026	Andrew D. Dickinson	CFO	Sell	3,000	$154.43	$463,290.00	167,779
2/17/2026	Johanna Mercier	Insider	Sell	28,000	$154.44	$4,324,320.00	120,288
2/5/2026	Daniel Patrick O'Day	CEO	Sell	115,640	$150.00	$17,346,000.00	613,912
1/28/2026	Daniel Patrick O'Day	CEO	Sell	10,000	$139.89	$1,398,900.00	556,698
1/23/2026	Daniel Patrick O'Day	CEO	Sell	115,640	$135.00	$15,611,400.00	566,698
1/20/2026	Jeffrey Bluestone	Director	Sell	5,000	$123.50	$617,500.00	8,920
1/15/2026	Andrew D. Dickinson	CFO	Sell	3,000	$124.31	$372,930.00	150,503
1/15/2026	Johanna Mercier	Insider	Sell	3,000	$124.31	$372,930.00	103,221
12/29/2025	Daniel Patrick O'Day	CEO	Sell	10,000	$124.83	$1,248,300.00	566,698
12/15/2025	Andrew D. Dickinson	CFO	Sell	3,000	$122.00	$366,000.00	153,503
12/15/2025	Johanna Mercier	Insider	Sell	3,000	$122.00	$366,000.00	106,221
11/28/2025	Daniel Patrick O'Day	CEO	Sell	10,000	$126.54	$1,265,400.00	571,203
11/28/2025	Jeffrey Bluestone	Director	Sell	5,000	$125.08	$625,400.00	8,920
11/28/2025	Kelly A. Kramer	Director	Sell	2,805	$127.10	$356,515.50	1,339
11/26/2025	Kelly A. Kramer	Director	Sell	2,806	$127.11	$356,670.66	1,339
11/17/2025	Andrew D. Dickinson	CFO	Sell	2,500	$125.23	$313,075.00	154,555
11/17/2025	Johanna Mercier	Insider	Sell	28,000	$125.86	$3,524,080.00	107,193
11/12/2025	Deborah H. Telman	EVP	Sell	53,646	$122.85	$6,590,411.10	43,676
10/28/2025	Daniel Patrick O'Day	CEO	Sell	10,000	$119.39	$1,193,900.00	581,203
10/15/2025	Andrew D. Dickinson	CFO	Sell	2,500	$118.08	$295,200.00	157,055
10/15/2025	Johanna Mercier	Insider	Sell	3,000	$118.08	$354,240.00	110,193
9/29/2025	Daniel Patrick O'Day	CEO	Sell	10,000	$111.66	$1,116,600.00	591,203
9/15/2025	Andrew D. Dickinson	CFO	Sell	2,500	$113.57	$283,925.00	159,555
9/15/2025	Johanna Mercier	Insider	Sell	3,000	$113.57	$340,710.00	113,193
8/28/2025	Daniel Patrick O'Day	CEO	Sell	10,000	$113.63	$1,136,300.00	595,725
8/15/2025	Andrew D. Dickinson	CFO	Sell	2,500	$118.53	$296,325.00	160,110
8/15/2025	Johanna Mercier	Insider	Sell	28,000	$118.53	$3,318,840.00	114,168
7/28/2025	Daniel Patrick O'Day	CEO	Sell	10,000	$113.94	$1,139,400.00	605,725
7/15/2025	Andrew D. Dickinson	CFO	Sell	2,500	$111.03	$277,575.00	162,610
7/15/2025	Andrew D. Dickinson	CFO	Sell	2,500	$111.03	$277,575.00	162,610
7/15/2025	Johanna Mercier	Insider	Sell	3,000	$111.03	$333,090.00	117,168
7/15/2025	Johanna Mercier	Insider	Sell	3,000	$111.03	$333,090.00	117,168
7/14/2025	Jeffrey Bluestone	Director	Sell	5,000	$109.74	$548,700.00	8,920
6/30/2025	Daniel Patrick O'Day	CEO	Sell	10,000	$110.45	$1,104,500.00	615,725
6/16/2025	Andrew D. Dickinson	CFO	Sell	2,500	$110.17	$275,425.00	165,110
6/16/2025	Johanna Mercier	Insider	Sell	3,000	$110.17	$330,510.00	120,168
5/30/2025	Daniel Patrick O'Day	CEO	Sell	10,000	$110.42	$1,104,200.00	620,268
5/22/2025	Johanna Mercier	Insider	Sell	28,000	$107.52	$3,010,560.00	121,152
5/15/2025	Andrew D. Dickinson	CFO	Sell	2,500	$99.82	$249,550.00	165,674
4/15/2025	Andrew D. Dickinson	CFO	Sell	2,500	$106.40	$266,000.00	168,174
3/10/2025	Andrew D. Dickinson	CFO	Sell	17,929	$118.17	$2,118,669.93	169,061
2/18/2025	Andrew D. Dickinson	CFO	Sell	2,500	$104.09	$260,225.00	169,061
2/12/2025	Andrew D. Dickinson	CFO	Sell	137,676	$102.22	$14,073,240.72	171,223
1/31/2025	Andrew D. Dickinson	CFO	Sell	142,180	$97.22	$13,822,739.60	129,873
1/15/2025	Andrew D. Dickinson	CFO	Sell	2,500	$91.35	$228,375.00	129,873
12/16/2024	Andrew D. Dickinson	CFO	Sell	8,500	$91.96	$781,660.00	132,373
11/29/2024	Andrew D. Dickinson	CFO	Sell	248,645	$92.76	$23,064,310.20	138,919
11/27/2024	Merdad Parsey	Insider	Sell	164,211	$91.92	$15,094,275.12	80,801
11/26/2024	Jeffrey Bluestone	Director	Sell	6,788	$91.39	$620,355.32	8,920
11/6/2024	Merdad Parsey	Insider	Sell	25,590	$91.50	$2,341,485.00	99,599
10/1/2024	Merdad Parsey	Insider	Sell	2,000	$83.83	$167,660.00	100,189
9/12/2024	Johanna Mercier	Insider	Sell	29,357	$83.78	$2,459,529.46	78,127
8/13/2024	Johanna Mercier	Insider	Sell	5,490	$73.98	$406,150.20	114,979
7/1/2024	Merdad Parsey	Insider	Sell	2,000	$68.63	$137,260.00	96,380
4/1/2024	Merdad Parsey	Insider	Sell	2,000	$72.96	$145,920.00	96,304
2/28/2024	Merdad Parsey	Insider	Sell	2,000	$73.18	$146,360.00	100,936
1/16/2024	Andrew D. Dickinson	CFO	Sell	5,000	$85.78	$428,900.00	101,534
1/9/2024	Johanna Mercier	Insider	Sell	8,242	$85.23	$702,465.66	82,729
10/17/2023	Andrew D. Dickinson	CFO	Sell	5,000	$80.00	$400,000.00	104,003

SEC Filings (Institutional Ownership Changes) for Gilead Sciences (NASDAQ:GILD)

83.67% of Gilead Sciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Gilead Sciences Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
9/15/2026	Anchor Investment Management LLC	2,831	$0.36M	0.0%	+843.7%	0.000%
9/11/2026	Bullseye Investment Management LLC	16,506	$2.09M	1.0%	N/A	0.001%
9/11/2026	Talon Private Wealth LLC	1,680	$0.21M	0.0%	N/A	0.000%
9/9/2026	Core Capital Management & Research inc.	318	$40K	0.0%	N/A	0.000%
9/9/2026	The Manufacturers Life Insurance Company	1,093,987	$138.21M	0.1%	-11.9%	0.088%
9/9/2026	Sequoia Financial Advisors LLC	58,662	$7.41M	0.0%	+16.9%	0.005%
9/9/2026	Tidal Investments LLC	545,861	$68.96M	0.1%	+8.8%	0.044%
9/9/2026	Cahill Financial Advisors Inc.	3,540	$0.45M	0.0%	-4.8%	0.000%
9/9/2026	MCF Advisors LLC	21,492	$2.72M	0.1%	+7.6%	0.002%
9/9/2026	Gemmer Asset Management LLC	3,554	$0.45M	0.0%	-4.1%	0.000%
9/9/2026	National Pension Service	3,062,393	$386.90M	0.2%	+1.4%	0.247%
9/9/2026	Engineers Gate Manager LP	112,886	$14.26M	0.2%	N/A	0.009%
9/9/2026	Cidel Asset Management Inc.	8,666	$1.10M	0.1%	+2.1%	0.001%
9/9/2026	Capital Analysts LLC	6,923	$0.88M	0.0%	+1.9%	0.001%
9/9/2026	SVB Wealth LLC	27,562	$3.48M	0.2%	+0.8%	0.002%
9/9/2026	Pinnacle Wealth Management Advisory Group LLC	33,876	$4.28M	0.3%	+1.5%	0.003%
9/9/2026	NorthRock Partners LLC	2,863	$0.36M	0.0%	+13.8%	0.000%
9/9/2026	Integrated Wealth Concepts LLC	35,492	$4.48M	0.0%	-1.3%	0.003%
9/9/2026	RFG Advisory LLC	12,955	$1.64M	0.0%	+0.9%	0.001%
9/9/2026	NewEdge Advisors LLC	442,389	$55.89M	0.2%	+12.7%	0.036%
9/9/2026	IFP Advisors Inc	8,347	$1.06M	0.0%	+17.7%	0.001%
9/9/2026	Baird Financial Group Inc.	292,295	$36.93M	0.1%	+3.6%	0.024%
9/8/2026	Allworth Financial LP	47,192	$5.96M	0.0%	-15.5%	0.004%
9/8/2026	Arizona State Retirement System	344,415	$43.51M	0.2%	+1.3%	0.028%
9/8/2026	Waverly Advisors LLC	30,793	$3.89M	0.0%	-9.0%	0.002%
9/8/2026	Empirical Finance LLC	43,580	$5.51M	0.2%	+3.4%	0.004%
9/8/2026	Nykredit A S	1,112,764	$140.59M	0.4%	N/A	0.090%
9/4/2026	Parkside Financial Bank & Trust	4,302	$0.54M	0.0%	+3.0%	0.000%
9/2/2026	Range Advisory LLC	2,668	$0.34M	0.0%	+15.5%	0.000%
9/1/2026	Parrish Capital LLC	19,540	$2.47M	2.0%	-14.1%	0.002%
8/27/2026	Corient Private Wealth LP	538,310	$68.01M	0.1%	-13.1%	0.043%
8/27/2026	Tucker Asset Management LLC	3,970	$0.50M	0.1%	+6.5%	0.000%
8/26/2026	Amundi	9,772,438	$1.23B	0.3%	-7.3%	0.788%
8/26/2026	HighTower Advisors LLC	1,534,627	$193.89M	0.2%	+5.8%	0.124%
8/25/2026	Advus Financial Partners LLC	5,689	$0.72M	0.2%	-2.5%	0.000%
8/25/2026	Groupe la Francaise	49,627	$6.27M	0.1%	+30.9%	0.004%
8/25/2026	VIRGINIA RETIREMENT SYSTEMS ET Al	1,032,295	$130.42M	0.8%	N/A	0.083%
8/23/2026	DMC Group LLC	11,396	$1.44M	1.0%	-10.3%	0.001%
8/23/2026	Washington Trust Advisors Inc.	705	$89K	0.0%	-26.5%	0.000%
8/23/2026	Ameritas Advisory Services LLC	7,390	$0.93M	0.0%	-11.3%	0.001%
8/23/2026	Wedmont Private Capital	32,598	$4.23M	0.1%	-0.5%	0.003%
8/23/2026	Kintra Wealth LLC	1,989	$0.28M	0.0%	+11.1%	0.000%
8/23/2026	Operose Advisors LLC	800	$0.10M	0.0%	-23.4%	0.000%
8/23/2026	HB Wealth Management LLC	51,132	$6.46M	0.0%	-10.2%	0.004%
8/23/2026	Saudi Central Bank	86,886	$10.98M	0.1%	+89.7%	0.007%
8/23/2026	Fortitude Advisory Group L.L.C.	1,769	$0.22M	0.1%	+7.0%	0.000%
8/23/2026	Azimuth Capital Investment Management LLC	95,985	$12.13M	0.4%	-0.5%	0.008%
8/22/2026	Compass Financial Management LLC	5,244	$0.67M	0.1%	N/A	0.000%
8/22/2026	AlphaGrep UK Ltd	5,212	$0.66M	0.2%	N/A	0.000%
8/22/2026	Maloon Powers Pitre Higgins & Dennehy LLC	2,859	$0.36M	0.1%	N/A	0.000%
8/22/2026	Markowski Investments	792	$100K	0.0%	N/A	0.000%
8/22/2026	Old Mission Investment Co LLC	3,253	$0.41M	0.1%	N/A	0.000%
8/22/2026	Strive Financial Group LLC	2,213	$0.28M	0.1%	+367.9%	0.000%
8/22/2026	Invested Advisors	3,024	$0.38M	0.3%	-17.1%	0.000%
8/22/2026	Munich Reinsurance Co Stock Corp in Munich	514,526	$65.01M	1.5%	-0.3%	0.041%
8/22/2026	Washington Growth Strategies LLC	3,062	$0.39M	0.2%	N/A	0.000%
8/22/2026	Syon Capital LLC	20,463	$2.59M	0.1%	-1.4%	0.002%
8/22/2026	TD Waterhouse Canada Inc.	482,201	$60.79M	0.2%	-12.8%	0.039%
8/22/2026	Premier Path Wealth Partners LLC	16,156	$2.04M	0.2%	+2.1%	0.001%
8/22/2026	United Community Bank	11,912	$1.51M	0.5%	+1.6%	0.001%
8/22/2026	Concurrent Investment Advisors LLC	81,664	$10.32M	0.1%	+8.6%	0.007%
8/22/2026	NEOS Investment Management LLC	950,430	$120.08M	0.4%	+11.3%	0.077%
8/22/2026	Allen Mooney & Barnes Investment Advisors LLC	15,709	$1.99M	0.3%	-5.0%	0.001%
8/21/2026	AXQ Capital LP	27,106	$3.43M	0.4%	N/A	0.002%
8/21/2026	iSAM Funds UK Ltd	16,000	$2.02M	1.4%	N/A	0.001%
8/21/2026	Greenspring Advisors LLC	3,135	$0.40M	0.0%	-2.5%	0.000%
8/21/2026	Nykredit A S	1,402,025	$177.13M	0.6%	N/A	0.113%
8/21/2026	Twin Lakes Capital Management LLC	58,267	$7.36M	2.4%	+0.3%	0.005%
8/21/2026	B. Metzler seel. Sohn & Co. AG	114,360	$14.45M	0.1%	+11.3%	0.009%
8/21/2026	Natural Investments LLC	7,354	$0.93M	0.2%	+4.0%	0.001%
8/21/2026	Cairn Investment Group Inc.	21,247	$2.68M	1.1%	-0.5%	0.002%
8/21/2026	Symphony Financial Ltd. Co.	3,533	$0.45M	0.1%	+39.8%	0.000%
8/21/2026	Chesapeake Wealth Management	2,477	$0.31M	0.1%	-14.7%	0.000%
8/21/2026	Acorn Wealth Advisors LLC	2,630	$0.33M	0.1%	+14.5%	0.000%
8/21/2026	Triumph Capital Management	3,687	$0.47M	0.1%	+2.2%	0.000%
8/21/2026	Legacy Financial Advisors Inc.	5,376	$0.68M	0.1%	-2.1%	0.000%
8/20/2026	Proficio Capital Partners LLC	4,405	$0.56M	0.0%	N/A	0.000%
8/20/2026	Nwam LLC	13,024	$1.65M	0.1%	+0.6%	0.001%
8/20/2026	Clifford Swan Investment Counsel LLC	11,357	$1.44M	0.0%	-4.7%	0.001%
8/20/2026	Railway Pension Investments Ltd	1,295,596	$163.69M	2.1%	-0.6%	0.104%
8/20/2026	F&V Capital Management LLC	4,200	$0.53M	0.1%	-32.3%	0.000%
8/20/2026	CTC Alternative Strategies Ltd.	3,000	$0.38M	0.6%	N/A	0.000%
8/20/2026	BTG Pactual Asset Management US LLC	4,213	$0.53M	0.0%	N/A	0.000%
8/20/2026	Headlands Technologies LLC	49,478	$6.25M	0.7%	N/A	0.004%
8/20/2026	Quantitative Investment Management LLC	44,223	$5.59M	0.6%	-17.0%	0.004%
8/20/2026	Ancora Advisors LLC	121,465	$15.35M	0.3%	-6.9%	0.010%
8/20/2026	Sigma Planning Corp	13,992	$1.77M	0.0%	-31.0%	0.001%
8/20/2026	Benjamin Edwards Inc.	125,525	$15.86M	0.1%	-5.0%	0.010%
8/20/2026	GTS Securities LLC	4,608	$0.58M	0.0%	-34.9%	0.000%
8/20/2026	Flputnam Investment Management Co.	70,944	$8.96M	0.1%	-48.8%	0.006%
8/20/2026	Northwestern Mutual Wealth Management Co.	92,216	$11.65M	0.0%	-6.4%	0.007%
8/20/2026	Wedbush Securities Inc.	25,113	$3.17M	0.1%	+3.9%	0.002%
8/20/2026	Meiji Yasuda Life Insurance Co	12,078	$1.53M	0.1%	-23.9%	0.001%
8/20/2026	Hennessy Advisors Inc.	85,199	$10.76M	0.3%	+24.7%	0.007%
8/20/2026	Spinnaker Trust	1,844	$0.23M	0.0%	+10.8%	0.000%
8/20/2026	Cullinan Associates Inc.	3,841	$0.49M	0.0%	-10.4%	0.000%
8/20/2026	Hollencrest Capital Management	744	$94K	0.0%	-9.5%	0.000%
8/20/2026	Greenleaf Trust	24,188	$3.06M	0.0%	-3.8%	0.002%
8/19/2026	Capital Advisors Inc. OK	3,611	$0.46M	0.0%	-5.0%	0.000%
8/19/2026	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	12,986,591	$1.64B	0.3%	-1.6%	1.047%

Data available starting January 2016

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Arcellx, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company was incorporated in 1987 and is headquartered in Foster City, California.

Today's Range

Now: $150.11

$149.57

$153.23

50 Day Range

MA: $139.58

$129.31

$151.22

52 Week Range

Now: $150.11

$108.46

$157.29

Volume

16,412,007 shs

Average Volume

6,966,534 shs

Market Capitalization

$186.13 billion

P/E Ratio

N/A

Dividend Yield

2.22%

Beta

0.33

Who are the company insiders with the largest holdings of Gilead Sciences?: Gilead Sciences' top insider investors include:
John Martin (CEO)
John C Martin (Chairman)
John C Martin (Insider)
John C Martin (CEO)
John C Martin (Director)
Norbert Bischofberger (EVP)
John F Milligan (CEO)
John F Milligan (Insider)
John F Milligan (COO)
Daniel Patrick O'day (CEO)
Learn More about top insider investors at Gilead Sciences.
Who are the major institutional investors of Gilead Sciences?: Gilead Sciences' top institutional investors include:
BlackRock Inc. — 9.81%
Bank of America Corp DE — 1.50%
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC — 1.05%
Wellington Management Group LLP — 1.02%
Legal & General Group Plc — 0.84%
Amundi — 0.79%
Learn More about top institutional investors of Gilead Sciences stock.
Which institutional investors are selling Gilead Sciences stock?: During the last quarter, GILD stock was sold by these institutional investors:
Bank of America Corp DE
Wellington Management Group LLP
Amundi
Van ECK Associates Corp
E. Ohman J or Asset Management AB
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
The Manufacturers Life Insurance Company
Corient Private Wealth LP
In the last year, company insiders that have sold Gilead Sciences company stock include:
Daniel Patrick O'day (CEO)
Andrew D Dickinson (CFO)
Johanna Mercier (Insider)
Deborah H Telman (EVP)
Anthony Welters (Director)
Jeffrey Bluestone (Director)
Kelly A Kramer (Director)
Learn More investors selling Gilead Sciences stock.
Which institutional investors are buying Gilead Sciences stock?: Within the previous quarter, GILD stock was bought by institutional investors including:
BlackRock Inc.
Legal & General Group Plc
Deutsche Bank AG
Jupiter Topco LLC
Mitsubishi UFJ Asset Management Co. Ltd.
Corient Private Wealth LP
Canada Pension Plan Investment Board
Caisse de depot et placement du Quebec